1. Boku N, Sugihara K, Kitagawa Y, Hatake K, Gemma A, Yamazaki N, Muro K, Hamaguchi T, Yoshino T, Yana I, Ueno H, Ohtsu A. Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patients. Jpn J Clin Oncol. 2014;44(3):214–23.
2. Dedeoglu F, Kim S. Henoch-Schönlein purpura (immunoglobulin A vasculitis): Clinical manifestations and diagnosis. UpToDate. 2015;23:3.
3. Kato K, Michishita Y, Oyama K, Hatano Y, Nozawa T, Ishibashi M, Konda R, Sasaki A. A case of Thrombotic Thrombocytopenic Purpura in a patient undergoing FOLFOX6 plus panitumumab therapy for unresectable recurrent rectal cancer with a rapidly progressive course. Gan To Kagaku Ryoho. 2016;43(1):133–6.
4. Yang K, Zhang T, Chen J, Fan L, Yin Z, Hu Y, Mu G. Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer. Head Neck. 2012;34(1):127–30.
5. Nozato K, Morishima Y, Furuta J, Fujita J, Miyazaki K, Ogawa R, Kikuchi N, Sakamoto T, Hizawa N. A case of Henoch-Schönlein purpura which was difficult to distinguish from a skin rash associated with gefitinib. Nihon Kokyuki Gakkai Zasshi. 2010;48(7):529–34.